eConsent In Healthcare Market: By Platform, By Enrollment Type, By Type, General Denial with Specific Consent, General Denial), and Region Forecast 2019-2030
The global e-Consent in healthcare market size was valued at US$ 397.2 million in 2023, at a CAGR of 9.7% from 2024-2030. The market is propelled by the growing need for simplified consent procedures and effective patient involvement. The move to digital solutions lowers administrative costs and improves compliance. Further driving market expansion are legislative mandates for informed consent and rising patient knowledge of their rights.
However, obstacles including worries about data privacy, the requirement for strong cybersecurity defenses, and opposition to departing from conventional consent procedures serve as limitations. The growing usage of electronic health data and telemedicine presents opportunities for seamless integration of eConsent. A more effective and user-friendly consent procedure in healthcare settings is ensured by the emergence of mobile health applications and AI-driven solutions that improve patient communication.
The e-Consent in healthcare market share is inclusive of several companies in this research report such as DocuSign, Net Health, Informed Corporation, Xcenda, Cognizant, Cegedim Health, Formstack, Wolters Kluwer, Evident, Medidata Solutions, Veeva Systems, Salesforce, and Oracle.
By Platform: Cloud-based platforms are the industry leaders in the eConsent in the healthcare market because of their scalability, flexibility, and accessibility for a wide range of healthcare institutions. They are perfect for healthcare providers with multiple locations since they allow for real-time changes and data sharing. On-premises platforms are more expensive up front and require more upkeep, but they are favored by businesses that demand complete control over their data and strict data privacy regulations. Software-as-a-service (SaaS) models are becoming more popular since they provide affordable solutions with less requirement for infrastructure. SaaS solutions are becoming more and more popular because of their simple integration, frequent upgrades, and improved security, especially for smaller healthcare organizations or those switching to digital systems. In general, SaaS and cloud-based platforms are propelling the market expansion.
By Enrollment Type: In the market for eConsent in healthcare industry, Remote Enrollment is growing increasingly prevalent, particularly due to the rise of telemedicine, virtual clinical trials, and home healthcare services. Remote enrollment allows patients to review and sign consent forms digitally from any location, improving convenience and accessibility, especially for clinical trials and telehealth services. Additionally, it expedites the consent process and lessens administrative hassles. On the other hand, On-site Enrollment remains crucial in traditional healthcare settings, such as hospitals and clinics, where in-person interactions are necessary for patient education and consent. However, remote enrolment’s efficiency and flexibility are propelling its quick uptake, especially in the digital and decentralized healthcare landscape of today.
By Type: In the eConsent in healthcare market, General Consent is the most widely used type, allowing healthcare providers to obtain broad patient approval for standard treatments and procedures, making it efficient for routine care. However, General Consent with Specific Denial(s) is gaining traction, as it offers patients more control by allowing them to approve most treatments while denying specific procedures or interventions, they may not be comfortable with. General Denial with Specific Consent(s) is less common but valuable in specialized cases where patients generally deny treatments but provide consent for specific actions. General Denial is the least used, as it limits treatment options significantly, but it may be employed in highly sensitive or patient-centered care settings.
Study Period
2024-2030Base Year
2023CAGR
9.7%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing use of digital healthcare solutions to enhance patient engagement and consent administration is the main factor driving the eConsent in the healthcare market. Efficient permission processes are necessary due to the growing usage of telemedicine and electronic health records (EHRs), which makes eConsent systems crucial for compliance. Stringent informed consent processes are mandated by regulatory frameworks like the Health Insurance Portability and Accountability Act (HIPAA) in the United States, which in turn drives demand for eConsent systems. Healthcare providers also want to lower the administrative expenses and mistakes related to paper-based permission forms. The eConsent industry is expanding as a result of patients' growing awareness of their rights and their need for more accessible, transparent consent procedures
The eConsent in healthcare market has obstacles despite its advantages. The worry for patient privacy and the security of sensitive data transferred and stored digitally is one of the main obstacles. Some businesses are discouraged from fully using eConsent systems due to concerns about cybersecurity and possible breaches of patient confidentiality. Furthermore, there is still a reluctance to move away from the conventional, paper-based permission processes, especially in areas with low levels of computer literacy. For smaller healthcare facilities, the initial expense of installing eConsent platforms which includes training personnel and connecting the systems with pre-existing EHR platforms also presents a hurdle. Adoption in international markets is further complicated by the need to make sure that eConsent systems abide by a variety of regional rules.
As the need for digital health platforms and telemedicine grows, there are substantial prospects in the eConsent in healthcare market. There is a chance to integrate eConsent systems and provide patients with more simple ways to provide informed consent as mobile health applications and wearable technology become more widely used. Furthermore, companies are investing in enhancing the user experience as healthcare becomes more patient-centric, which opens up prospects for the creation of eConsent platforms that are easier to use and more intuitive. eConsent technologies may provide seamless consent management, enabling substantial development potential in the healthcare sector, especially in places where access to physical healthcare is limited. This is especially true given the growing emphasis on remote healthcare and the expansion of clinical trials.
The increasing usage of cloud-based consent management systems and mobile health(mHealth) Platforms, which streamline and improve accessibility to the process are prominent developments in the econsent healthcare market. With individual permission forms available and real-time help, artificial intelligence (AI) and machine learning (ML) are being integrated into e-consent systems to improve patient comprehension and communication. Blockchain technology has shown potential as a safe way to handle and keep consent data while maintaining integrity and openness. Using multilingual e-consent platforms to accommodate a variety of patient demographics and make consent procedures more inclusive in another trend. The use of econsent is also speeding up due to the movement in health care system toward growing completely.
The widespread use of electronic health records (EHRs)and the growing regulatory requirements, such as the HIPPA, which requires stringent informed consent practices, are driving the eConsent in the healthcare market in the US. Due to the high degree of digitalization in the American healthcare system and its emphasis on increasing patient participation, eConsent solutions are essential for boosting efficiency and compliance. The digital consent process needs to be frictionless, especially in light of the expanding usage of telemedicine, particularly in the post-pandemic context. Additionally, the need for safe and open eConsent systems has been spurred by growing patient knowledge of their rights and the value of data privacy. The US continues to be a vital market for innovations in digital consent solutions and healthcare technology.
Strong regional growth has been observed in the e-consent healthcare market with North America dominating the market due to its sophisticated healthcare infrastructure widespread use of electronic health records (EHRs) and strict regulations such as HIPAA that place a strong emphasis on informed consent. Driven by the General Data Protection Regulation (GDPR) and growing healthcare digitalization Europe follows. The rapid digital revolution in health care, rising telemedicine use, and pro-eHealth government measures are driving market expansion in the Asia Pacific. Adaption must be solved, though, by issues including poorer access to the internet and inadequate infrastructure in the same places. As the health care system develops, Latin America, and Middle East & Africa have rising promise, but at a slower rate due to the infrastructure and economic limitations.
The eConsent in healthcare industry in North America is propelled by the region's sophisticated healthcare infrastructure, strict legal frameworks, and broad use of digital health technologies. With laws like HIPAA mandating stringent informed consent procedures and the expanding usage of electronic health records (EHRs) and telemedicine, the U.S. leads the region in eConsent demand. Driven by its goal of enhancing patient participation and modernizing healthcare, Canada is likewise implementing eConsent. The emphasis on patient rights, data privacy, and minimizing administrative constraints in North America contributes to the market's expansion.
Furthermore, North America is positioned as a leading participant in the global eConsent market thanks to the region's significant investments in health IT and advancements in digital consent platforms.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 397.2 million |
|
Market CAGR |
9.7% |
|
By Platform |
|
|
By Enrollment Type |
|
|
By Type |
|
|
By Region |
|
The need for more effective consent procedures and the growing trend toward digital healthcare solutions are driving significant growth in the eConsent in the Healthcare Market. The use of eConsent systems is being driven by regulatory regulations, such as HIPAA and GDPR, to assure compliance and improve patient involvement. Demand is also being increased by the growth of clinical trials, telemedicine, and remote healthcare services. The market is changing as a result of innovations like blockchain technology for secure data management and AI-driven consent systems. However, there are still issues with cybersecurity and data privacy. In general, the industry is expected to grow rapidly as healthcare digitization spreads throughout the world.
Download Free Sample Report
The global e-Consent in healthcare market size was valued at US$ 397.2 million in 2023, growing at a CAGR of 9.7% from 2024-2030.
• Increasing use of digital health solutions.
• Growing utilization of electronic health records (EHRs) and telemedicine.
• Laws requiring informed permission (such as GDPR and HIPAA).
• Increasing patient consciousness and desire for clear consent procedures.
• Connecting telemedicine platforms with eConsent systems.
• Usage of mobile health (mHealth) apps to obtain consent is growing.
• Adoption of AI-powered methods to obtain individualized patient consent.
• Increasing interest in using blockchain technology to manage data securely.
DocuSign, Net Health, Informed Corporation, Xcenda, Cognizant, Cegedim Health, Formstack, Wolters Kluwer, Evident, Medidata Solutions, Veeva Systems, Salesforce, and Oracle), are the key companies in the e-Consent healthcare market.
The key segments covered in the research report are fuel platform, enrolment type, type, and region.
| 1.Executive Summary |
| 2.Global eConsent In Healthcare Market Introduction |
| 2.1.Global eConsent In Healthcare Market - Taxonomy |
| 2.2.Global eConsent In Healthcare Market - Definitions |
| 2.2.1.Platform |
| 2.2.2.Enrollment Type |
| 2.2.3.Type |
| 2.2.4.Region |
| 3.Global eConsent In Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global eConsent In Healthcare Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global eConsent In Healthcare Market By Platform, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Cloud-Based |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. On-Premises |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software-as-a-Service (SaaS) |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global eConsent In Healthcare Market By Enrollment Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. On-site |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Remote |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global eConsent In Healthcare Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. General Consent |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. General Consent with Specific Denial(s) |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. General Denial with Specific Consent(s) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. General Denial |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global eConsent In Healthcare Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America eConsent In Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Platform Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cloud-Based |
| 9.1.2.On-Premises |
| 9.1.3.Software-as-a-Service (SaaS) |
| 9.2. Enrollment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.On-site |
| 9.2.2.Remote |
| 9.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.General Consent |
| 9.3.2.General Consent with Specific Denial(s) |
| 9.3.3.General Denial with Specific Consent(s) |
| 9.3.4.General Denial |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe eConsent In Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Platform Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cloud-Based |
| 10.1.2.On-Premises |
| 10.1.3.Software-as-a-Service (SaaS) |
| 10.2. Enrollment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.On-site |
| 10.2.2.Remote |
| 10.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.General Consent |
| 10.3.2.General Consent with Specific Denial(s) |
| 10.3.3.General Denial with Specific Consent(s) |
| 10.3.4.General Denial |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) eConsent In Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Platform Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cloud-Based |
| 11.1.2.On-Premises |
| 11.1.3.Software-as-a-Service (SaaS) |
| 11.2. Enrollment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.On-site |
| 11.2.2.Remote |
| 11.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.General Consent |
| 11.3.2.General Consent with Specific Denial(s) |
| 11.3.3.General Denial with Specific Consent(s) |
| 11.3.4.General Denial |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) eConsent In Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Platform Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cloud-Based |
| 12.1.2.On-Premises |
| 12.1.3.Software-as-a-Service (SaaS) |
| 12.2. Enrollment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.On-site |
| 12.2.2.Remote |
| 12.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.General Consent |
| 12.3.2.General Consent with Specific Denial(s) |
| 12.3.3.General Denial with Specific Consent(s) |
| 12.3.4.General Denial |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America eConsent In Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Platform Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cloud-Based |
| 13.1.2.On-Premises |
| 13.1.3.Software-as-a-Service (SaaS) |
| 13.2. Enrollment Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.On-site |
| 13.2.2.Remote |
| 13.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.General Consent |
| 13.3.2.General Consent with Specific Denial(s) |
| 13.3.3.General Denial with Specific Consent(s) |
| 13.3.4.General Denial |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.DocuSign |
| 14.2.2.Net Health |
| 14.2.3.Informed Corporation |
| 14.2.4.Xcenda |
| 14.2.5.Cognizant |
| 14.2.6.Cegedim Health |
| 14.2.7.Formstack |
| 14.2.8.Wolters Kluwer |
| 14.2.9.Evident |
| 14.2.10.Medidata Solutions |
| 14.2.11.Veeva Systems |
| 14.2.12.Salesforce |
| 14.2.13.Oracle |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Sravani is a proficient Business Analyst with an MBA and a background in Computer Science, with seven years of experience in the field of market research. Sravani is adept at creating competitive evaluations, precise market estimations, and market projections, emphasizing the food and beverage and information and communication technology (ICT) industries. Her areas of competence are identifying important players, projecting market trends, and assessing the potential for industry growth. She applies a strong analytical approach to provide precise market estimates and thorough industry analysis, empowering organizations to make data-driven decisions. Sravani's estimating and forecasting abilities are essential for businesses to take advantage of new opportunities and effectively manage dynamic market environments.
Download Free Sample
